找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Malignant Pleural Mesothelioma; Advances in Pathogen Takashi Nakano,Takashi Kijima Book 2021 Springer Nature Singapore Pte Ltd. 2021 Asbest

[复制链接]
查看: 50389|回复: 51
发表于 2025-3-21 19:57:13 | 显示全部楼层 |阅读模式
书目名称Malignant Pleural Mesothelioma
副标题Advances in Pathogen
编辑Takashi Nakano,Takashi Kijima
视频video
概述Provides essential information on molecular genetics, epidemiology, translational research, and the latest results of clinical trials on mesothelioma.Consists of 5 themed sections: epidemiology, patho
丛书名称Respiratory Disease Series: Diagnostic Tools and Disease Managements
图书封面Titlebook: Malignant Pleural Mesothelioma; Advances in Pathogen Takashi Nakano,Takashi Kijima Book 2021 Springer Nature Singapore Pte Ltd. 2021 Asbest
描述This book provides essential information on recent advances in molecular genetics, epidemiology, translational research, and the latest results of clinical trials on mesothelioma. Significant progress has been made in understanding mesothelioma biology, and in developing new therapies for this refractory tumor, malignant pleural mesothelioma (MPM). Not only does this volume summarize the latest research-based data on the disease; it also shares insights into future research directions..The book consists of 5 themed sections on: epidemiology, pathogenesis, screening and early detection, molecular genetics, and clinical aspects and management. Several chapters focus on new trends in the field, e.g. immune therapy and identification of biomarkers, molecular oncogenesis including genetic susceptibility, and molecular diagnostic pathology. The book also highlights new cancer treatment approaches, such as immunotherapy based on immune checkpoint inhibitors, which has meanta paradigm shift in other types of cancer, and given some hope to MPM patients. In turn, it discusses recent molecular pathological studies on mesothelioma, which claim to offer more accurate classifications than tradit
出版日期Book 2021
关键词Asbestos; Biomolecular Pathways; Pleural Plaque; Cancer Screening; Cytopathologic Diagnosis; Liquid Biops
版次1
doihttps://doi.org/10.1007/978-981-15-9158-7
isbn_softcover978-981-15-9160-0
isbn_ebook978-981-15-9158-7Series ISSN 2509-5552 Series E-ISSN 2509-5560
issn_series 2509-5552
copyrightSpringer Nature Singapore Pte Ltd. 2021
The information of publication is updating

书目名称Malignant Pleural Mesothelioma影响因子(影响力)




书目名称Malignant Pleural Mesothelioma影响因子(影响力)学科排名




书目名称Malignant Pleural Mesothelioma网络公开度




书目名称Malignant Pleural Mesothelioma网络公开度学科排名




书目名称Malignant Pleural Mesothelioma被引频次




书目名称Malignant Pleural Mesothelioma被引频次学科排名




书目名称Malignant Pleural Mesothelioma年度引用




书目名称Malignant Pleural Mesothelioma年度引用学科排名




书目名称Malignant Pleural Mesothelioma读者反馈




书目名称Malignant Pleural Mesothelioma读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:13:47 | 显示全部楼层
发表于 2025-3-22 02:57:54 | 显示全部楼层
发表于 2025-3-22 05:35:37 | 显示全部楼层
发表于 2025-3-22 11:43:04 | 显示全部楼层
发表于 2025-3-22 16:42:42 | 显示全部楼层
发表于 2025-3-22 17:39:11 | 显示全部楼层
发表于 2025-3-22 21:52:58 | 显示全部楼层
发表于 2025-3-23 02:04:56 | 显示全部楼层
Giovanni Gaudino,Michael Minaai,Michele Carbone,Haining Yangss several important questions: for which parts (or kinds of parts) is Mg best suited? What are the predominant engineering challenges preventing use of Mg for these parts? Where do we, as a materials science and engineering community, start in pursuing solutions to these challenges?
发表于 2025-3-23 07:53:59 | 显示全部楼层
ss several important questions: for which parts (or kinds of parts) is Mg best suited? What are the predominant engineering challenges preventing use of Mg for these parts? Where do we, as a materials science and engineering community, start in pursuing solutions to these challenges?
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-14 22:16
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表